Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
01-Oct-2025 | 689.95 | 718.2 | 684.6 | 715.45 | 19,255 | 27,78,59,652.35 | 2,12,478 |
03-Oct-2025 | 720 | 744.8 | 720 | 728.2 | 17,747 | 26,79,03,457.9 | 1,29,285 |
06-Oct-2025 | 728.2 | 739.5 | 713 | 718.05 | 7,802 | 9,90,24,511.45 | 68,370 |
07-Oct-2025 | 718.05 | 723.75 | 705.5 | 709 | 5,352 | 7,56,59,930.7 | 58,283 |
08-Oct-2025 | 709 | 717.75 | 700.75 | 714.8 | 10,398 | 12,67,24,536.3 | 74,632 |
09-Oct-2025 | 717 | 732.95 | 706.9 | 720.25 | 9,327 | 13,19,07,182.6 | 59,294 |
10-Oct-2025 | 725 | 744.5 | 716 | 732.15 | 12,411 | 21,11,84,153.5 | 1,31,915 |
13-Oct-2025 | 730 | 735 | 715 | 717.2 | 5,511 | 8,74,13,207.5 | 68,029 |
14-Oct-2025 | 722 | 727 | 705.1 | 714.65 | 12,536 | 16,34,36,445.9 | 1,13,640 |
15-Oct-2025 | 724.45 | 728.8 | 715.6 | 717.95 | 5,455 | 7,41,25,909.8 | 48,644 |
16-Oct-2025 | 728.65 | 755.5 | 718.05 | 740.3 | 25,864 | 45,96,02,958.75 | 2,33,049 |
17-Oct-2025 | 740 | 740.05 | 712.7 | 714.9 | 10,698 | 14,23,36,039.85 | 1,22,809 |
20-Oct-2025 | 721 | 734.75 | 714.9 | 729.7 | 7,664 | 10,26,98,249.7 | 66,315 |
21-Oct-2025 | 740.1 | 753.65 | 736 | 750.2 | 4,938 | 10,53,18,142.15 | 91,929 |
23-Oct-2025 | 754.05 | 761.15 | 741.9 | 745.35 | 8,929 | 13,64,50,895.05 | 90,972 |
24-Oct-2025 | 751.3 | 772 | 740.5 | 768.45 | 13,601 | 28,76,09,459.9 | 2,05,842 |
27-Oct-2025 | 777.7 | 784.2 | 762 | 773.15 | 22,202 | 30,18,69,220.45 | 1,77,542 |
28-Oct-2025 | 773.15 | 790 | 770.75 | 784 | 13,575 | 22,10,01,959.85 | 1,52,416 |
29-Oct-2025 | 782.05 | 786 | 768.1 | 773.75 | 5,765 | 12,13,49,940.35 | 94,971 |
30-Oct-2025 | 772.8 | 787 | 772.65 | 775.45 | 5,719 | 11,37,83,770.4 | 68,807 |
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
